(Q28729782)

12 November 2017

title

Prevention and control of dengue-the light at the end of the tunnel (English)

1 reference

12 November 2017

0 references

0 references

3

Duane J Gubler

0 references

author name string

Tikki Pang

series ordinal

1

1 reference

12 November 2017

Tippi K Mak

series ordinal

2

1 reference

12 November 2017

publication date

6 February 2017

1 reference

Lancet Infectious Diseases

12 November 2017

published in

2 references

12 November 2017

volume

17

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

e79-e87

1 reference

Dengue--an infectious disease of staggering proportions

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Disease and economic burdens of dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

1 reference

7 January 2021

Economic and disease burden of dengue illness in India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Cost of dengue cases in eight countries in the Americas and Asia: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Economic and disease burden of dengue in Southeast Asia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Cost of dengue outbreaks: literature review and country case studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Refining the global spatial limits of dengue virus transmission by evidence-based consensus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

The global distribution and burden of dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Underrecognized mildly symptomatic viremic dengue virus infections in rural Thai schools and villages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Comparison of three fluid solutions for resuscitation in dengue shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

1 reference

7 January 2021

Present and future arboviral threats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Current approaches in antiviral drug discovery against the Flaviviridae family

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Sequential episodes of dengue--Puerto Rico, 2005-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Homotypic Dengue Virus Reinfections in Nicaraguan Children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Dengue viruses cluster antigenically but not as discrete serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Effect of increasing age on the trend of dengue and dengue hemorrhagic fever in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Predictive tools for severe dengue conforming to World Health Organization 2009 criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Global spread and persistence of dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

The pathogenesis of dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Reduced risk of disease during postsecondary dengue virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Potential opportunities and perils of imperfect dengue vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

The effects of tertiary and quaternary infections on the epidemiology of dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Heterogeneous feeding patterns of the dengue vector, Aedes aegypti, on individual human hosts in rural Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Climatic factors driving invasion of the tiger mosquito (Aedes albopictus) into new areas of Trentino, northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

A review of the invasive mosquitoes in Europe: ecology, public health risks, and control options

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

An outbreak of dengue virus serotype 1 infection in Cixi, Ningbo, People's Republic of China, 2004, associated with a traveler from Thailand and high density of Aedes albopictus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Autochthonous dengue fever, Tokyo, Japan, 2014.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Health and climate change: the end of the beginning?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Impact of regional climate change on human health

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Potential changes in the distribution of dengue transmission under climate warming.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Region-wide synchrony and traveling waves of dengue across eight countries in Southeast Asia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Effects of the El Niño-southern oscillation on dengue epidemics in Thailand, 1996-2005.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Assessing the roles of temperature, precipitation, and enso in dengue re-emergence on the Texas-Mexico border region

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Cities spawn epidemic dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Dynamic spatiotemporal trends of dengue transmission in the Asia-Pacific region, 1955-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Dengue, Urbanization and Globalization: The Unholy Trinity of the 21(st) Century

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Dengue: knowledge gaps, unmet needs, and research priorities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Dengue: challenges for policy makers and vaccine developers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Trials and tribulations on the path to developing a dengue vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Identifying protective dengue vaccines: guide to mastering an empirical process

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Next generation dengue vaccines: A review of the preclinical development pipeline

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Latest developments and future directions in dengue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Dengue vaccines: recent developments, ongoing challenges and current candidates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Efficacy of a tetravalent dengue vaccine in children in Latin America.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

A Candidate Dengue Vaccine Walks a Tightrope

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Development of a recombinant, chimeric tetravalent dengue vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

PUBLIC HEALTH. Dengue vaccines at a crossroad

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Beyond efficacy: The full public health impact of vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Controlling dengue with vaccines in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Assessing the potential of a candidate dengue vaccine with mathematical modeling

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Dengue vector-control services: how do they work? A systematic literature review and country case studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Assessing the relationship between vector indices and dengue transmission: a systematic review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Dengue prevention and 35 years of vector control in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

The history of dengue outbreaks in the Americas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde, the Green Way): cluster randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Bacillus thuringiensis israelensis (Bti) for the control of dengue vectors: systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Field efficacy of new larvicide products for control of multi-resistant Aedes aegypti populations in Martinique (French West Indies).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Pyrethroid resistance in Aedes aegypti and Aedes albopictus from Port-au-Prince, Haiti

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Temephos resistance in Aedes aegypti in Colombia compromises dengue vector control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Evaluation of novel insecticides for control of dengue vector Aedes aegypti (Diptera: Culicidae).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Research in mosquito control: current challenges for a brighter future

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Field evaluation of the establishment potential of wMelPop Wolbachia in Australia and Vietnam for dengue control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

From lab to field: the influence of urban landscapes on the invasive potential of Wolbachia in Brazilian Aedes aegypti mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Mosquito control might not bolster imperfect dengue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Suppression of a Field Population of Aedes aegypti in Brazil by Sustained Release of Transgenic Male Mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Transgenic mosquitoes and the fight against malaria: managing technology push in a turbulent GMO world.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

The ecology of genetically modified mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Declining malaria, rising of dengue and Zika virus: insights for mosquito vector control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

A critical assessment of vector control for dengue prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Challenges and future perspective for dengue vector control in the Western Pacific Region

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Quantifying the Epidemiological Impact of Vector Control on Dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Climate change and human health: impacts, vulnerability and public health.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Introducing new vaccines into developing countries: obstacles, opportunities and complexities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Global public health security

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

A role for vector control in dengue vaccine programs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

The partnership for dengue control - a new global alliance for the prevention and control of dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Moving towards universal health coverage: lessons from 11 country studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

Valuing vaccines: deficiencies and remedies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930471-6

7 January 2021

10.1016/S1473-3099(16)30471-6

Identifiers

DOI

1 reference

12 November 2017

1 reference